JP2000501073A - １−アリールスルホニル、アリール（チオ）カルボニルピリダジノ誘導体及び製造法 - Google Patents

１−アリールスルホニル、アリール（チオ）カルボニルピリダジノ誘導体及び製造法

Info

Publication number
JP2000501073A
JP2000501073A JP9518177A JP51817797A JP2000501073A JP 2000501073 A JP2000501073 A JP 2000501073A JP 9518177 A JP9518177 A JP 9518177A JP 51817797 A JP51817797 A JP 51817797A JP 2000501073 A JP2000501073 A JP 2000501073A
Authority
JP
Japan
Prior art keywords
diazo
hexahydro
hexahydrophenanthrene
benzo
cyclohepta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP9518177A
Other languages
English (en)
Japanese (ja)
Inventor
コームス，ドナルド・ダブリユー
Original Assignee
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド filed Critical オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド
Publication of JP2000501073A publication Critical patent/JP2000501073A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36—Benzo-cinnolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP9518177A 1995-11-06 1996-10-10 １−アリールスルホニル、アリール（チオ）カルボニルピリダジノ誘導体及び製造法 Ceased JP2000501073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US790095P 1995-11-06 1995-11-06
US60/007,900 1995-11-06
PCT/US1996/016227 WO1997017332A1 (en) 1995-11-06 1996-10-10 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation

Publications (1)

Publication Number Publication Date
JP2000501073A true JP2000501073A (ja) 2000-02-02

Family

ID=21728709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9518177A Ceased JP2000501073A (ja) 1995-11-06 1996-10-10 １−アリールスルホニル、アリール（チオ）カルボニルピリダジノ誘導体及び製造法

Country Status (17)

Country Link
JP (1) JP2000501073A (no)
KR (1) KR100360614B1 (no)
CN (1) CN1110485C (no)
AU (1) AU704507B2 (no)
BR (1) BR9611407A (no)
CZ (1) CZ286789B6 (no)
HU (1) HU225162B1 (no)
IL (1) IL124320A (no)
MX (1) MX9803605A (no)
NO (1) NO310460B1 (no)
NZ (1) NZ319979A (no)
PL (1) PL185618B1 (no)
RU (1) RU2175969C2 (no)
TW (1) TW460467B (no)
UA (1) UA48989C2 (no)
WO (1) WO1997017332A1 (no)
ZA (1) ZA969298B (no)

Also Published As

Publication number Publication date
AU704507B2 (en) 1999-04-22
BR9611407A (pt) 1999-12-28
CN1110485C (zh) 2003-06-04
CZ286789B6 (en) 2000-07-12
KR100360614B1 (ko) 2003-06-02
CZ138098A3 (cs) 1998-09-16
PL326669A1 (en) 1998-10-12
CN1207091A (zh) 1999-02-03
TW460467B (en) 2001-10-21
HU225162B1 (en) 2006-07-28
PL185618B1 (pl) 2003-06-30
AU7263796A (en) 1997-05-29
NO982030D0 (no) 1998-05-05
IL124320A (en) 2001-10-31
HUP0201305A2 (hu) 2002-12-28
MX9803605A (es) 1998-09-30
NO310460B1 (no) 2001-07-09
HUP0201305A3 (en) 2003-02-28
NO982030L (no) 1998-06-23
IL124320A0 (en) 1998-12-06
NZ319979A (en) 1999-11-29
UA48989C2 (uk) 2002-09-16
ZA969298B (en) 1998-05-05
WO1997017332A1 (en) 1997-05-15
KR19990067340A (ko) 1999-08-16
RU2175969C2 (ru) 2001-11-20

Similar Documents

Publication Publication Date Title
JP3536258B2 (ja) エストロゲンに関連する新生物及び病気の処置に有用な新規なインドール誘導体類
JP2000513362A (ja) アンドロゲン受容体モジュレーター化合物及び方法
JPH0570463A (ja) Ｎ−アシル−２，３−ベンゾジアゼピン誘導体、その製造法、それを含有する製剤組成物、およびその製造法
US5866567A (en) Diazepinones, their production and use
AU4810400A (en) 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
JP2002517405A (ja) アゴニストまたはアンタゴニストホルモン特性を有する１７β−ニトロ−１１β−アリルステロイドとその誘導体
EP0650480B1 (en) 1-arylsulphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
KR100611289B1 (ko) 작용제 또는 길항제 호르몬 특성을 갖는 17β-아미노 및히드록실아미노-11β-아릴스테로이드 및 그의 유도체
US6780862B2 (en) Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
US5753655A (en) 1-arylsulphonyl, arylcarbonyl and arylthiocarbonyl pyridazino derivatives and methods of preparation
JP2000501073A (ja) １−アリールスルホニル、アリール（チオ）カルボニルピリダジノ誘導体及び製造法
JP4027969B2 (ja) 置換ジベンズ［ａ，ｆ］アズレンおよび調製方法
JP2003519683A (ja) Ｍｃｐ−１受容体アンタゴニストとしてのインドール誘導体
EP1520856A1 (en) Androgen receptor agonist
JP2024517453A (ja) 含窒素複素環ピリジン化合物
EP0837850A1 (en) 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
CA2236896C (en) 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation
JP2003519684A (ja) Ｍｃｐ−１レセプターアンタゴニストとしてのインドール誘導体
JPH0739415B2 (ja) ピロリジン誘導体
JP2003073374A (ja) ２環性芳香族アミン誘導体
AU2014298230C1 (en) Novel forms of co-crystals of agomelatine and p-toluenesulphonic acid, method for preparing same and the pharmaceutical compositions containing same
JP2003509509A (ja) ５−アミノアルキル及び５−アミノカルボニル置換されたインドール類
JPH0948777A (ja) ジアゼピノン類、その製造法および剤
JP2002514641A (ja) ベンゾカルバゾールおよびインデノインドール誘導のエストロゲン物質
AU2002246725A1 (en) Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070828

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20080116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080304